| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
12,947 |
1,495 |
$2.74M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,547 |
3,196 |
$583K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
21,955 |
2,141 |
$532K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
15,289 |
2,041 |
$328K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,225 |
3,012 |
$255K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,432 |
932 |
$213K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,107 |
2,708 |
$115K |
| 71046 |
Radiologic examination, chest; 2 views |
3,229 |
2,511 |
$107K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,631 |
2,280 |
$104K |
| 71045 |
Radiologic examination, chest; single view |
4,351 |
2,484 |
$103K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,197 |
2,087 |
$95K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,136 |
6,283 |
$93K |
| 80053 |
Comprehensive metabolic panel |
10,870 |
8,129 |
$83K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,405 |
5,555 |
$82K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,758 |
9,772 |
$72K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,024 |
769 |
$70K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,524 |
1,186 |
$59K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,096 |
2,429 |
$57K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
479 |
393 |
$50K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
528 |
399 |
$35K |
| 97116 |
|
1,982 |
312 |
$32K |
| 80061 |
Lipid panel |
2,680 |
2,388 |
$26K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
938 |
804 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,895 |
1,658 |
$23K |
| 83880 |
|
1,097 |
835 |
$23K |
| 74018 |
|
741 |
609 |
$22K |
| G0515 |
Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes |
1,678 |
144 |
$21K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,245 |
335 |
$21K |
| 83013 |
|
356 |
307 |
$20K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,652 |
2,338 |
$19K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
232 |
152 |
$18K |
| 84484 |
|
2,347 |
1,690 |
$17K |
| 97129 |
|
1,347 |
167 |
$16K |
| 92526 |
|
448 |
68 |
$16K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
347 |
80 |
$12K |
| 83605 |
|
1,860 |
1,317 |
$11K |
| 72100 |
|
168 |
142 |
$10K |
| 87807 |
|
832 |
754 |
$10K |
| 97130 |
|
828 |
123 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
2,906 |
2,156 |
$9K |
| 81025 |
|
1,366 |
1,142 |
$8K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
70 |
15 |
$7K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
352 |
48 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
247 |
141 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
885 |
729 |
$5K |
| 97024 |
|
861 |
106 |
$5K |
| 81001 |
|
2,898 |
2,294 |
$5K |
| 97542 |
|
358 |
94 |
$5K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
149 |
54 |
$5K |
| 97535 |
Self-care/home management training, each 15 minutes |
364 |
92 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
87 |
81 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
301 |
259 |
$5K |
| 82553 |
|
571 |
414 |
$4K |
| 82652 |
|
214 |
197 |
$4K |
| 81003 |
|
2,262 |
1,924 |
$4K |
| 73560 |
|
112 |
84 |
$4K |
| 83690 |
|
526 |
433 |
$3K |
| G0378 |
Hospital observation service, per hour |
17 |
14 |
$3K |
| 83655 |
|
247 |
225 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
379 |
276 |
$2K |
| 84145 |
|
2,059 |
1,478 |
$2K |
| 87187 |
|
131 |
97 |
$2K |
| 80305 |
|
218 |
180 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
55 |
51 |
$2K |
| 97161 |
|
51 |
41 |
$2K |
| 85379 |
|
268 |
229 |
$2K |
| 87040 |
|
195 |
96 |
$2K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
692 |
121 |
$1K |
| 82607 |
|
94 |
87 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
25 |
25 |
$1K |
| 87481 |
|
68 |
49 |
$947.40 |
| 82150 |
|
159 |
135 |
$872.60 |
| 73610 |
|
32 |
24 |
$840.94 |
| 87186 |
|
122 |
97 |
$837.88 |
| 87641 |
|
64 |
55 |
$789.50 |
| 82552 |
|
63 |
52 |
$779.18 |
| 87640 |
|
64 |
55 |
$757.92 |
| 83735 |
|
132 |
107 |
$749.66 |
| 97165 |
|
28 |
14 |
$723.62 |
| 92523 |
|
15 |
12 |
$655.81 |
| 73630 |
|
25 |
13 |
$590.53 |
| 97162 |
|
14 |
12 |
$538.59 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
14 |
12 |
$512.44 |
| 85018 |
|
214 |
197 |
$402.99 |
| 85014 |
|
213 |
196 |
$400.86 |
| 84439 |
|
48 |
37 |
$396.52 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
17 |
14 |
$389.95 |
| 85651 |
|
140 |
136 |
$388.84 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
81 |
28 |
$376.39 |
| 85610 |
|
122 |
86 |
$372.08 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
163 |
136 |
$334.50 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
22 |
15 |
$321.11 |
| 87088 |
|
37 |
29 |
$301.15 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
146 |
75 |
$284.79 |
| 82043 |
|
68 |
63 |
$268.98 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
14 |
$222.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
32 |
31 |
$110.94 |
| 82550 |
|
15 |
15 |
$101.36 |
| 84550 |
|
31 |
28 |
$91.29 |
| 90686 |
|
12 |
12 |
$65.12 |
| G9169 |
Memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
32 |
14 |
$36.14 |
| 99497 |
|
29 |
26 |
$2.33 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
248 |
177 |
$1.62 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
37 |
28 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
52 |
41 |
$0.00 |
| 36416 |
|
114 |
108 |
$0.00 |
| G9168 |
Memory functional limitation, current status at therapy episode outset and at reporting intervals |
27 |
13 |
$0.00 |
| G8990 |
Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals |
228 |
163 |
$0.00 |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
137 |
137 |
$0.00 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
18 |
16 |
$0.00 |